mail
versión imprimible
 
 

12th World ADC London 2022

Evvnt Promotion / evvnt
-
29.03.2022 - 01.04.2022  Hotel Novotel London West, International Ctre, 1 Shortlands, Hammersmith, W6 8DR London, United Kingdom
Time: 08:00 to 16:00
 
Temas de la conferencia
With the approvals of Zynlonta and Tivdak within the last 12 months there are now 11 commercially available ADCs on the market. Furthermore, recent Enhertu and Polivy data suggests that ADCs could be soon be used as earlier line treatments to improve patient outcomes sooner. Undoubtedly, the momentum and inspiration that ADCs and ADC developers are gathering means that it's an incredibly exciting time for the entire community.
Organizador profesional (PCO)
Hanson Wade
Observaciones
URLs:
Brochure: https://go.evvnt.com/944846-3?pid=4832
LinkedIn: https://go.evvnt.com/944846-4?pid=4832
Twitter: https://go.evvnt.com/944846-5?pid=4832

Speakers: Sunil Verma, Global Head and Head of Breast Cancer Strategy, AstraZeneca, and more.
 

Información e inscripción:

https://go.evvnt.com/944846-2?pid=4832
Mr. Hanson Wade
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
GBP 1999.00 - GBP 4495.00
Los participantes esperaban
1000 - 1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichische Gesellschaft für Public HealthÄrzte der WeltCharité International AcademynewTreeÖsterreichische Akademie der ÄrzteEuropean Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AMREF - African Medical and Research Foundation